Cannabis Law Report
MAY 18, 2022
Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results.
Cannabis Law Report
MAY 18, 2022
NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Hemp Roundtable, the hemp industry’s national advocacy organization. “The The methods for both phases were the same.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MMJ Recs
NOVEMBER 30, 2023
While anecdotal evidence and individual success stories have sparked interest in using MMJ for seizure control, scientific research plays a crucial role in establishing its safety and efficacy. Additionally, MMJ has been associated with better sleep patterns among some epilepsy patients.
MMJ Recs
NOVEMBER 17, 2023
Maryland residents have reported experiencing reduced pain, increased mobility, better sleep, and improved mental health as a result of MMJ treatments. Over time, Maryland has refined its approach to ensure the accessibility and safety of MMJ for its residents. It oversees licensing, quality control, and patient access.
Veriheal
JANUARY 24, 2023
From pain relief to improved sleep patterns, there are countless anecdotal and scientific reports touting the potential benefits of cannabis for those with neurological disorders—including Parkinson’s disease. As a result, cannabis advocacy groups urged the agency to recognize cannabis’ medicinal value and treat it equally.
Cannabis Law Report
JUNE 23, 2021
The analysis of patient-reported outcome measures following treatment with cannabis-based medicinal products (CBMPs) in a study covering patients with all conditions found statistically significant improvements in anxiety, sleep , and general quality of life at one, three, and six months following treatment, compared to baseline assessment.
Cannabis Law Report
APRIL 12, 2019
I use medical cannabis for my skin, pain, mood, fatigue, appetite and, most importantly, sleep. Patient advocacy is alive and well in Canada. The mandate of the legalisation of recreational cannabis was to regulate, to keep cannabis out of the hands of our children and profits out of the hands of criminals, and to ensure public safety.
Expert insights. Personalized for you.
52 
Let's personalize your content